ArticleFrontiers in cellular and infection microbiology2026
Duration of same-species antimicrobial non-susceptibility persistence in urinary gram-negative bacilli: a 12-year within-patient cohort study.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Prior urine-culture results can guide empiric antimicrobial therapy, but their value depends on whether the same organism recurs and the prior phenotype remains informative. We estimated the duration of same-species antimicrobial non-susceptibility persistence among urinary gram-negative bacilli in a tertiary-care cohort. Methods: We conducted a retrospective longitudinal cohort study of urine cultures from patients aged ≥12 years at Aseer Central Hospital, Saudi Arabia, from 2013 to 2024. Consecutive within-patient, same-species isolate pairs were formed for gram-negative bacilli. Among pairs in which the prior isolate was non-susceptible and the next same-species isolate was class-evaluable, persistence was defined as non-susceptibility of the next isolate to the same drug class. Estimates were stratified by organism, drug class, and time since the prior isolate; uncertainty was addressed using patient-clustered bootstrap or Wilson intervals, and temporal decay used modified Poisson regression. Results: The source cohort included 14,587 eligible urinary gram-negative bacilli cultures from 8,045 patients. The trajectory cohort included 2,401 patients with ≥2 eligible cultures, yielding 4,332 consecutive same-species pairs from 1,745 patients; 3,380 pairs from 1,368 patients entered class-evaluable persistence analyses. Discussion: Prior same-species urinary gram-negative bacilli non-susceptibility carried substantial empiric memory, especially for fluoroquinolones, but persistence declined with time and differed by organism and drug class. Prior results should be interpreted as time-dependent, species- and class-specific evidence, not as an indefinite resistance flag.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.